4.3 out of 5 stars
(6 Ratings)
TrustInSoft commercializes a source code analyzer called TrustInSoft Analyzer, which analyzes C and C++ code and mathematically guarantees the absence of defects, immunity of software components to the most common security flaws, and compliance with a specification. The technology is recognized by U.S. federal agency the National Institute of Standards and Technology (NIST), and was the first in the world to meet NIST’s SATE V Ockham Criteria for high quality software.
The key differentiator for TrustInSoft Analyzer is its use of mathematical approaches called formal methods, which allow for an exhaustive analysis to find all the vulnerabilities or runtime errors and only raises true alarms.
Companies who use TrustInSoft Analyzer reduce their verification costs by 4, efforts in bug detection by 40, and obtain an irrefutable proof that their software is safe and secure.
The experts at TrustInSoft can also assist clients in training, support and additional services.
Learn more about TrustInSoft Analyzer
4.8 out of 5 stars
(139 Ratings)
Tractian is the Industrial Copilot for maintenance and reliability, combining hardware and software solutions to monitor asset performance, manage industrial operations, and implement predictive maintenance strategies. Its AI-driven platform empowers businesses to prevent unplanned equipment downtime and boost production output. The company is headquartered in Atlanta, GA, and extends its presence globally with offices in Mexico City and Sao Paulo. Learn more at tractian.com.
Learn more about TRACTIAN
Illumina DRAGEN Secondary Analysis
The Illumina DRAGEN Secondary Analysis system offers precise, thorough, and highly efficient processing of next-generation sequencing data. Utilizing a graph reference genome alongside machine learning techniques, it achieves remarkable accuracy. The workflow is exceptionally streamlined, capable of completely analyzing a 34x whole human genome in approximately 30 minutes when using the DRAGEN server v4. Additionally, it enhances this workflow by compressing FASTQ file sizes by up to five times. This system is adept at analyzing a variety of NGS data types, including whole genomes, exomes, methylomes, and transcriptomes. It is designed to be compatible with the user's preferred platform and is scalable to meet varying requirements. DRAGEN analysis consistently ranks as a leader in accuracy for both germline and somatic variant detection, as evidenced by its performance in industry competitions conducted by precisionFDA. This advanced analysis solution empowers laboratories of all sizes and specialties to maximize the potential of their genomic datasets. Moreover, the implementation of highly adaptable field-programmable gate array (FPGA) technology allows DRAGEN to deliver hardware-accelerated genomic analysis algorithms, further enhancing its performance. Such advancements position DRAGEN as a vital tool in the ever-evolving field of genomics.
Learn more about Illumina DRAGEN Secondary Analysis
Geneious
Geneious Prime enhances access to bioinformatics by converting raw datasets into intuitive visual representations that facilitate sequence analysis in a user-friendly manner. It offers straightforward sequence assembly along with the convenient editing of contigs. Users benefit from automatic gene prediction, motif identification, translation, and variant calling through its annotation features. It also allows for the genotyping of microsatellite traces using automated ladder fitting and peak calling, producing comprehensive tables of alleles. The platform showcases beautifully designed visualizations of annotated genomes and assemblies, presented in a customizable sequence view that enhances user experience. Furthermore, it supports powerful analyses of SNP variants, simplifies RNA-Seq expression evaluations, and assists in amplicon metagenomics. Users can also design and test PCR and sequencing primers while developing their own searchable primer database. Additionally, Geneious Biologics provides a versatile, scalable, and secure solution to optimize workflows for antibody analysis, enabling the creation of high-quality libraries and the selection of the most suitable therapeutic candidates. This integration of tools fosters greater efficiency and innovation in biological research.
Learn more about Geneious
